Rhumbline Advisers trimmed its holdings in Arteris, Inc. (NASDAQ:AIP - Free Report) by 47.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,066 shares of the company's stock after selling 36,908 shares during the quarter. Rhumbline Advisers owned about 0.10% of Arteris worth $277,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors also recently bought and sold shares of AIP. CWM LLC grew its holdings in Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock worth $71,000 after purchasing an additional 10,005 shares during the period. Cambridge Investment Research Advisors Inc. purchased a new position in shares of Arteris during the first quarter valued at approximately $95,000. Strs Ohio bought a new stake in shares of Arteris in the 1st quarter worth approximately $104,000. D. E. Shaw & Co. Inc. purchased a new stake in shares of Arteris in the 4th quarter worth approximately $110,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Arteris in the 4th quarter worth approximately $160,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
AIP has been the subject of a number of recent research reports. Wall Street Zen upgraded Arteris from a "sell" rating to a "hold" rating in a research note on Monday, September 15th. TD Cowen lifted their price target on Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $15.00.
Read Our Latest Report on AIP
Arteris Trading Down 2.1%
Arteris stock opened at $9.84 on Friday. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $14.29. The stock has a fifty day simple moving average of $9.54 and a two-hundred day simple moving average of $8.30. The firm has a market cap of $419.68 million, a price-to-earnings ratio of -12.00 and a beta of 1.44.
Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The firm had revenue of $16.50 million for the quarter, compared to the consensus estimate of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts forecast that Arteris, Inc. will post -0.73 EPS for the current fiscal year.
Insider Transactions at Arteris
In related news, COO Laurent R. Moll sold 8,129 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $8.74, for a total transaction of $71,047.46. Following the transaction, the chief operating officer owned 386,552 shares in the company, valued at $3,378,464.48. This represents a 2.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Paul L. Alpern sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $8.88, for a total transaction of $88,800.00. Following the completion of the sale, the vice president owned 73,587 shares in the company, valued at $653,452.56. This represents a 11.96% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 470,911 shares of company stock valued at $5,573,464. Company insiders own 29.10% of the company's stock.
Arteris Profile
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.